A decision analysis to determine the appropriate treatment for low-risk myelodysplastic syndromes.

被引：0
|
作者：
Sekeres, MA [1 ]
Fu, AZ [1 ]
Maciejewski, JP [1 ]
Golshayan, AR [1 ]
Kalaycio, M [1 ]
Kattan, MW [1 ]
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2533
引用
收藏
页码：711A / 711A
页数：1
相关论文
共 50 条
  • [31] Detection of risk groups in myelodysplastic syndromes.: A multicenter study
    Belli, C
    Acevedo, S
    Bengio, R
    Arrossagaray, G
    Watman, N
    Rossi, N
    García, J
    Flores, G
    Goldztein, S
    Larripa, I
    HAEMATOLOGICA, 2002, 87 (01) : 9 - 16
  • [32] Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes
    Ma, Xiaomei
    Wang, Rong
    Galili, Naomi
    Mayne, Susan T.
    Wang, Sa A.
    Yu, Herbert
    Raza, Azra
    CANCER CAUSES & CONTROL, 2011, 22 (04) : 623 - 629
  • [33] Use of steroids in the management of low-risk myelodysplastic syndromes with autoimmune features
    Fattizzo, Bruno
    Serpenti, Fabio
    Versino, Francesco
    Cassanello, Giulio
    Cro, Lilla M.
    Barbieri, Marzia
    Croci, Giorgio A.
    Revelli, Nicoletta
    Porta, Matteo G. Della
    Barcellini, Wilma
    BLOOD TRANSFUSION, 2023, 21 (05) : 452 - 460
  • [34] Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes
    R. Tehranchi
    Medical Oncology, 2006, 23 (1) : 37 - 49
  • [35] Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes
    Tehranchi, R
    MEDICAL ONCOLOGY, 2006, 23 (01) : 37 - 49
  • [36] Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes
    Xiaomei Ma
    Rong Wang
    Naomi Galili
    Susan T. Mayne
    Sa A. Wang
    Herbert Yu
    Azra Raza
    Cancer Causes & Control, 2011, 22 : 623 - 629
  • [37] Association of amifostine and erythropoietin for the treatment of anemia in myelodysplastic syndromes.
    Musto, P
    Grossi, A
    Balestri, F
    Scalzulli, PR
    D'Arena, G
    Sanpaolo, MG
    Mantuano, SF
    Bodenizza, CA
    Falcone, A
    Rossi-Ferrini, P
    Carotenuto, M
    BLOOD, 2000, 96 (11) : 262B - 262B
  • [38] Cyclosporine a without or with thalidomide for the treatment of patients with Myelodysplastic syndromes.
    Xiao, Zhijian
    Xu, Zefeng
    Wang, Jianxiang
    Hao, Yushu
    BLOOD, 2007, 110 (11) : 222B - 222B
  • [39] Granulocyte colony-stimulating factor and erythropoietin reduce mitochondria-dependent apoptosis of erythroid progenitors in low-risk myelodysplastic syndromes.
    Tehranchi, R
    Fadeel, B
    Forsblom, AM
    Christensson, B
    Samuelsson, J
    Howe, RB
    Zhivotovsky, B
    Hellstrom-Lindberg, E
    BLOOD, 2002, 100 (11) : 165A - 166A
  • [40] Part 4: Myelodysplastic syndromes-Treatment of low-risk patients with the 5q deletion
    Meira Magalhaes, Silvia Maria
    Pereira Velloso, Elvira Deolinda Rodrigues
    Buzzini, Renata
    Bernardo, Wanderley Marques
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2018, 40 (03) : 274 - 277
12345